Revelation Biosciences's total assets for Q3 2025 were $12.86M, an increase of 138.30% from the previous quarter. REVB total liabilities were $1.85M for the fiscal quarter, a 18.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.